|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-10-2
|
|
pubmed:abstractText |
Patient adherence to prescribed antiviral therapy in human immunodeficiency virus infection enhances response. We evaluated the impact of adherence to combination therapy with interferon or peginterferon plus ribavirin in chronic hepatitis C patients.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
pubmed-author:AlbrechtJanice KJK,
pubmed-author:CapronJJ,
pubmed-author:DienstagJulesJ,
pubmed-author:GaraudJean-JacquesJJ,
pubmed-author:International Hepatitis Interventional Therapy Group,
pubmed-author:LeeWilliam MWM,
pubmed-author:LindsayKaren LKL,
pubmed-author:MannsMichaelM,
pubmed-author:McHutchisonJohn GJG,
pubmed-author:PatelKeyurK,
pubmed-author:PoynardThierryT,
pubmed-author:TrepoChristianC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
123
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1061-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:12360468-Adult,
pubmed-meshheading:12360468-Antiviral Agents,
pubmed-meshheading:12360468-Drug Therapy, Combination,
pubmed-meshheading:12360468-Female,
pubmed-meshheading:12360468-Genotype,
pubmed-meshheading:12360468-Hepacivirus,
pubmed-meshheading:12360468-Hepatitis C, Chronic,
pubmed-meshheading:12360468-Humans,
pubmed-meshheading:12360468-Interferon-alpha,
pubmed-meshheading:12360468-Interferons,
pubmed-meshheading:12360468-Male,
pubmed-meshheading:12360468-Middle Aged,
pubmed-meshheading:12360468-Polyethylene Glycols,
pubmed-meshheading:12360468-Recombinant Proteins,
pubmed-meshheading:12360468-Retrospective Studies,
pubmed-meshheading:12360468-Ribavirin,
pubmed-meshheading:12360468-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.
|
|
pubmed:affiliation |
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA. mchutool@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
